Zynerba Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Zynerba Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2023.
  • Zynerba Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $85.5K, a 10.1% increase year-over-year.
  • Zynerba Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $302K, a 2.71% decline from 2021.
  • Zynerba Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $310K, a 2.55% decline from 2020.
  • Zynerba Pharmaceuticals, Inc. annual Operating Lease, Payments for 2020 was $319K, a 4.28% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $85.5K +$7.83K +10.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $77.7K -$6.04K -7.21% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $83.7K +$21.5K +34.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $62.3K +$1.36K +2.23% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q1 2019 $60.9K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.